Skip to main content

Find Clinical Trials

Home
Conditions
Malignant Neoplasm

Clinical trial condition

Malignant Neoplasm

Explore clinical trials studying Malignant Neoplasm. Study availability and eligibility vary by location and protocol.

164 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Malignant Neoplasm trial results

Recruiting

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

NCT07247110

Conditions: Malignant Neoplasm, Neoplasms
Locations: Rutgers Cancer Institute of New Jersey ( Site 0052) New Brunswick, New Jersey, United States

NEXT Oncology ( Site 0051) Irving, Texas, United States

NEXT Virginia ( Site 0054) Fairfax, Virginia, United States

Blacktown Hospital ( Site 0455) Sydney, New South Wales, Australia

View all 19 locations

View Trial Details

Recruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

NCT04453072

Conditions: Body Weight, Malignant Neoplasm, Neoplasms, +7 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Project: Every Child for Younger Patients With Cancer

NCT02402244

Conditions: Adrenal Gland Pheochromocytoma, Bone Marrow Diseases, Carcinoma, +59 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Kingman Regional Medical Center Kingman, Arizona, United States

View all 278 locations

View Trial Details

Recruiting

Norris ORIEN Total Cancer Care

NCT02970045

Conditions: Cancer Risk, Malignant Neoplasm, Neoplasms
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

NCT06012695

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +7 more
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

Taichung Veterans General Hospital Taichung, Taiwan

Koo Foundation Sun Yat-Sen Cancer Center Taipei, Taiwan

Linkou Chang-Gung Memorial Hospital Taoyuan City, Taiwan

View Trial Details

Recruiting

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

NCT06385925

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

NEXT Oncology San Antonio, Texas, United States

NEXT Virginia Fairfax, Virginia, United States

Anhui Provincial Cancer Hospital Hefei, Anhui, China

View all 19 locations

View Trial Details

Recruiting

Intraoperative Tumor Margin Identification With ICG Dye Imaging

NCT04752137

Conditions: Benign Neoplasm, Malignant Neoplasm, Neoplasms
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

NCT02688517

Conditions: Malignant Neoplasm, Neoplasms
Locations: Ocean Medical Center Brick, New Jersey, United States

Bayshore Community Hospital Holmdel, New Jersey, United States

RWJBarnabas Health - Jersey City Medical Center, Jersey City Jersey City, New Jersey, United States

Southern Ocean County Medical Center Manahawkin, New Jersey, United States

View Trial Details

Recruiting

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

NCT03207854

Conditions: Healthy Subject, Hematologic Diseases, Hematologic Neoplasms, +8 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

NCT07487883

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details